AI Insight
Researchers at the University of Ottawa Faculty of Medicine have led an international study identifying a previously hidden signaling pathway that may explain why glioblastoma, the most aggressive and treatment-resistant brain cancer in adults, consistently evades current therapies. The discovery of this signaling axis could potentially open new avenues for drug development targeting this devastating cancer.
Why it matters
Glioblastoma has extremely poor patient outcomes due to its resistance to existing treatments, making new therapeutic targets critically important. Understanding this hidden signaling mechanism could lead to the development of novel drugs that circumvent the resistance pathways that make current treatments ineffective.
An international study led by a scientist at the University of Ottawa Faculty of Medicine is opening new frontiers in the fight against glioblastoma (GB), a devastating cancer behind the most malignant and treatment-resistant brain tumors in adults.
Source: Why glioblastoma keeps beating treatment: Hidden signaling axis could open new drug path